NCT05057650

Brief Summary

The purpose of this study is to evaluate the impact of community health screening, health education and nutritional intervention on risk factors for cardiovascular disease in a predominantly African American population. The health fair and intervention will take place in a church that typically improves their lifestyle by "giving up for Lent" certain foods or habits. Participation in this nutrition intervention is voluntary and each participant will sign an informed consent along with a waiver. On the waiver, the participant can agree to have all testing performed but can withdraw consent at any time or decide to have only some of the testing. It was hypothesized that a community-based health screening and nutritional intervention will have a positive impact on the participants by:

  1. 1.Measuring baseline risk factors
  2. 2.Educating them about their individual risk for heart disease
  3. 3.Providing education on healthy lifestyle
  4. 4.Providing a nutritional intervention for 40 days with home- delivered plant-based meals nutrition that has been shown to lower cardiac risk factors
  5. 5.Repeating the risk factor assessment at the end of the intervention, to demonstrate the degree of, if any, reduction in cardiac risk as assessed by the American College of Cardiology/American Heart Association (ACC/AHA) Atherosclerotic Cardiovascular Disease (ASCVD) Risk Calculator
  6. 6.Motivating at-risk subjects to seek continued appropriate medical care and to institute more permanent relevant lifestyle changes (e.g., diet, exercise, medication compliance).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 3, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2019

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 20, 2020

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

August 9, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 27, 2021

Completed
Last Updated

October 1, 2021

Status Verified

September 1, 2021

Enrollment Period

2 months

First QC Date

August 9, 2021

Last Update Submit

September 25, 2021

Conditions

Keywords

Nutrition Interventionplant-based nutritioncardiovascular risk modification

Outcome Measures

Primary Outcomes (1)

  • American College of Cardiology/American Heart Association (ACC/AHA) Atherosclerotic Cardiovascular Disease (ASCVD) Risk Calculator, ranging from 1% to 50% 10-year event risk

    ACC/AHA Guideline for Prevention Tool calculated based on blood pressure, total cholesterol, HDL cholesterol, diabetes, age, gender, ethnicity, and smoking history.

    5 weeks

Study Arms (1)

Intervention

EXPERIMENTAL

Vegan food for 5 weeks: approximately 50 participants volunteered for the intervention.

Dietary Supplement: Vegan diet

Interventions

Vegan dietDIETARY_SUPPLEMENT

Provide

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>18
  • Able to consent to dietary protocol
  • Willing to comply with study requirements and voluntarily agrees to participate in this clinical study after appropriate informed consent is provided.

You may not qualify if:

  • Vegetarians
  • Inability to regularly measure blood pressure if taking antihypertensive medications
  • Inability to regularly measure blood sugar if taking antihyperglycemic medications
  • Celiac disease (gluten enteropathy)
  • Treatment for eating disorder
  • Active treatment for malignancy
  • Inability to eat solid food
  • Fruit, nut or vegetable
  • Age \>18
  • Able to consent to dietary protocol
  • Willing to comply with study requirements and voluntarily agrees to participate in this clinical study after appropriate informed consent is provided.
  • Vegetarians
  • Inability to regularly measure blood pressure if taking antihypertensive medications
  • Inability to regularly measure blood sugar if taking antihyperglycemic medications
  • Celiac disease (gluten enteropathy)
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rush University Medical Center

Chicago, Illinois, 60612, United States

Location

MeSH Terms

Conditions

Risk Reduction BehaviorNutrition Disorders

Interventions

Diet, Vegan

Condition Hierarchy (Ancestors)

BehaviorNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Diet, VegetarianDiet, Plant-BasedDiet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief, Cardiology Division, James B. Herrick Professor of Medicine

Study Record Dates

First Submitted

August 9, 2021

First Posted

September 27, 2021

Study Start

March 3, 2019

Primary Completion

April 20, 2019

Study Completion

March 20, 2020

Last Updated

October 1, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations